Crocker Ventures LLC Invests in Anzenbio LLC, Producer of Bio-pathogen and Bio-threat Portable Detection Devices.Business Editors/Health/Medical Writers BIOWIRE2K SALT LAKE CITY--(BUSINESS WIRE)--June 10, 2004 Crocker Ventures LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control has completed an initial round of equity funding Equity funding An investment consisting of a life insurance policy and a mutual fund. The insurance policy is paid by the collateral value of fund shares, giving the investor the advantages of insurance protection with the growth potential of a mutual fund. for a new Salt Lake-based biotech venture, Anzenbio LLC. Anzenbio specializes in the development and manufacture of field deployable electrochemical electrochemical /elec·tro·chem·i·cal/ (-kem´i-k'l) pertaining to interaction or interconversion of chemical and electrical energies. e·lec·tro·chem·i·cal adj. pathogen Pathogen Any agent capable of causing disease. The term pathogen is usually restricted to living agents, which include viruses, rickettsia, bacteria, fungi, yeasts, protozoa, helminths, and certain insect larval stages. detectors and microarray biosensor A device that detects and analyzes body movement, temperature or fluids and turns it into an electronic signal. See lab on a chip and data glove. Biosensor chips. Crocker Venture LLC has invested $1 million in the initial investment round, along with credit line provisions and commitments to provide additional equity funding as product milestones are attained. The primary target markets for the new technology are agricultural pathogens for high-value cash crops, bio-threat agent monitoring, and the industrial hygiene detection of molds and fungus in commercial and residential real estate. "Anzenbio's lightweight and portable electrochemical detector and proprietary biosensor chip system is applicable to a wide range of bio-pathogen market applications, and provides the most sensitive and stable detection platform available in a field deployable unit," noted Gary L. Crocker, president of Crocker Ventures LLC. "By depositing a layer of antibodies specific to a target pathogen on the biosensor chip, the user can accurately and inexpensively detect pathogens in the field without sending samples to conventional test laboratories." In addition to his capital investment, Crocker will serve as chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. for the new firm. Dr. Pat Williams, Anzenbio's president and founder, said, "This initial investment will allow us to introduce to the marketplace later this year the first two commercial applications of our electrochemical detector system. The first will address the worldwide market for field detection of specific agricultural pathogens in the citrus and vineyard industries, and the second will facilitate the detection of environmentally relevant threat agents that generate health hazards health hazard Occupational safety Any agent or activity posing a potential hazard to health. Cf Physical hazard. monitored by environmental inspectors and industrial hygienists. At the same time, we are aggressively pursuing the broad-based application of our system for the field detection of bio-threat agents." Crocker Ventures LLC is an "early stage" seed capital investment firm focusing on health care and biotech ventures. Other current investments include Interleuken Genetics Inc. and Merrimack Pharmaceuticals in Boston, and 1-800-Patches, Enliven en·liv·en tr.v. en·liv·ened, en·liv·en·ing, en·liv·ens To make lively or spirited; animate. en·liv  en·er n. Nutraceuticals, and Thermoform Technologies in Utah. Anzenbio LLC develops, manufactures, and markets a low-cost and portable electrochemical bio-pathogen and bio-threat detection system. The firm produces and markets a field deployable detector and compatable proprietary microarray biosensors with antibody assays for agricultural, environmental, and bio-threat pathogen testing. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion